Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report.

Corrigan, Margaret, Haydon, Geoffrey, Thompson, Fiona M, Rajoriya, Neil, Peplow, Claire L, Hubscher, Stefan G, Steven, Neil, Hirschfield, Gideon M and Armstrong, Matthew J (2019) Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report. JHEP reports (Online), 1 (1). pp. 66-69. ISSN 2589-5559.

Full text not available from this repository.
Official URL: https://www.ncbi.nlm.nih.gov/pubmed/?term=32039353
Item Type: Article
Subjects: QU Biochemistry
QW Microbiology. Immunology
WI Digestive system. Gastroenterology
Divisions: Planned IP Care > Gastroentrology
Related URLs:
Depositing User: Mr Muneeb Liaquat
Date Deposited: 14 Feb 2020 15:21
Last Modified: 14 Feb 2020 15:21
URI: http://www.repository.uhblibrary.co.uk/id/eprint/2851

Actions (login required)

View Item View Item